15-42164465-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_015289.5(VPS39):c.1919G>T(p.Gly640Val) variant causes a missense change. The variant allele was found at a frequency of 0.000237 in 1,613,916 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )
Consequence
VPS39
NM_015289.5 missense
NM_015289.5 missense
Scores
3
10
6
Clinical Significance
Conservation
PhyloP100: 5.67
Genes affected
VPS39 (HGNC:20593): (VPS39 subunit of HOPS complex) This gene encodes a protein that may promote clustering and fusion of late endosomes and lysosomes. The protein may also act as an adaptor protein that modulates the transforming growth factor-beta response by coupling the transforming growth factor-beta receptor complex to the Smad pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 18 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS39 | NM_015289.5 | c.1919G>T | p.Gly640Val | missense_variant | 19/25 | ENST00000318006.10 | NP_056104.2 | |
VPS39 | NM_001301138.3 | c.1952G>T | p.Gly651Val | missense_variant | 20/26 | NP_001288067.1 | ||
VPS39 | XM_011521403.3 | c.1952G>T | p.Gly651Val | missense_variant | 20/26 | XP_011519705.1 | ||
VPS39 | XM_011521404.3 | c.1919G>T | p.Gly640Val | missense_variant | 19/25 | XP_011519706.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS39 | ENST00000318006.10 | c.1919G>T | p.Gly640Val | missense_variant | 19/25 | 1 | NM_015289.5 | ENSP00000326534 | P4 | |
VPS39 | ENST00000348544.4 | c.1952G>T | p.Gly651Val | missense_variant | 20/26 | 1 | ENSP00000335193 | A1 | ||
VPS39 | ENST00000561818.1 | n.262G>T | non_coding_transcript_exon_variant | 1/2 | 3 | |||||
VPS39 | ENST00000562258.5 | n.1413G>T | non_coding_transcript_exon_variant | 2/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152188Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
18
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251382Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135866
GnomAD3 exomes
AF:
AC:
20
AN:
251382
Hom.:
AF XY:
AC XY:
14
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000249 AC: 364AN: 1461728Hom.: 0 Cov.: 31 AF XY: 0.000239 AC XY: 174AN XY: 727162
GnomAD4 exome
AF:
AC:
364
AN:
1461728
Hom.:
Cov.:
31
AF XY:
AC XY:
174
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74346
GnomAD4 genome
AF:
AC:
18
AN:
152188
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
10
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2023 | The c.1919G>T (p.G640V) alteration is located in exon 19 (coding exon 19) of the VPS39 gene. This alteration results from a G to T substitution at nucleotide position 1919, causing the glycine (G) at amino acid position 640 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at